Healthcare -
Biotechnology - NASDAQ - CH
$ 38.02
-6.3 %
$ 2.41 B
Market Cap
-20.78
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
MoonLake Immunotherapeutics
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 142 M |
| Operating Income | 0 |
| Other Expenses | 121 M |
| Net Income | -121 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 0 | 13.2 K | 12.4 K | 4.97 K | 0 |
| Gross Profit | 0 | 13.2 K | 12.4 K | 4.97 K | 0 |
| OPERATING INCOME | |||||
| Operating Expenses | 141.7 | 54.1 | 65.1 | 53.6 | 0.1 |
| Selling, General and Administrative Expenses | 30.3 | 22.3 | 23.0 | 18.0 | 0.1 |
| Research and Development Expenses | 111.4 | 31.8 | 42.0 | 35.5 | 0 |
| Operating Income | 0 | (54.1) | (65.1) | (53.6) | (0.1) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | 0 | 10.1 | 0.6 | 10.7 | 14.9 K |
| Pre-Tax Income | (121.0) | (44.0) | (64.5) | (53.6) | 90.8 K |
| NET INCOME | |||||
| Tax Provision | 0.3 | 94.4 K | 36.4 K | 4.76 K | (0.2) |
| Net Income | (120 680.0) | (36.0) | (64.5) | (53.6) | 90.8 K |
| EPS | 1.92 K | 0.73 | 2.2 | 6.84 | 0.0061 |